What to Do with an Abnormal Newborn Screen for Severe Combined Immune Deficiency

Area of Science:

• Immunology
• Genetics
• Pediatrics

Background:

• Severe combined immunodeficiency (SCID) is a group of rare genetic disorders.
• Newborn screening for SCID has been implemented nationwide in the United States.
• Screening identifies infants with T-cell lymphopenia, a potential indicator of SCID.

Purpose of the Study:

• To highlight the importance of understanding state-specific newborn screening protocols for SCID.
• To emphasize the need for effective patient assessment and management strategies.
• To address the communication challenges in delivering SCID diagnosis to families.

Main Methods:

• Review of current newborn screening practices for SCID.
• Discussion of diagnostic pathways following abnormal screening results.
• Consideration of clinical immunologist training needs.

Main Results:

• Newborn screening for SCID is universally available across all 50 states.
• Abnormal screening requires further diagnostic testing to confirm SCID.
• Variations in screening programs necessitate tailored clinical approaches.

Conclusions:

• Clinical immunologists must be knowledgeable about their state's specific SCID screening process.
• Developing standardized assessment protocols is crucial for effective patient management.
• Training immunologists in sensitive communication for delivering SCID diagnoses to families is essential.